Verition Fund Management LLC Novavax Inc Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

A detailed history of Verition Fund Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 37,483 shares of NVAX stock, worth $318,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,483
Previous 88,301 57.55%
Holding current value
$318,980
Previous $1.12 Million 57.65%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.71 - $17.11 $544,260 - $869,495
-50,818 Reduced 57.55%
37,483 $473,000
Q2 2024

Aug 14, 2024
BUY
$3.89 - $20.97 $343,490 - $1.85 Million
88,301 New
88,301 $1.12 Million
Q3 2023

Nov 14, 2023
BUY
$6.81 - $9.74 $320,751 - $458,754
47,100 New
47,100 $341,000
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $488,448 - $1.06 Million
84,800 New
84,800 $587,000
Q3 2022

Nov 14, 2022
SELL
$18.2 - $76.12 $54 - $228
-3 Reduced 0.03%
10,835 $197,000
Q2 2022

Aug 15, 2022
BUY
$36.28 - $75.29 $393,202 - $815,993
10,838 New
10,838 $557,000
Q1 2022

May 13, 2022
SELL
$69.73 - $142.9 $225,785 - $462,710
-3,238 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$134.56 - $217.97 $186,500 - $302,106
1,386 Added 74.84%
3,238 $463,000
Q3 2021

Nov 15, 2021
BUY
$177.8 - $270.58 $329,285 - $501,114
1,852 New
1,852 $384,000
Q3 2020

Nov 16, 2020
SELL
$79.44 - $178.51 $550,122 - $1.24 Million
-6,925 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$13.86 - $83.61 $95,980 - $578,999
6,925 New
6,925 $577,000

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email